Customer Logins

Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.

Customer Logins

Healthcare Consulting - Market Access, Pricing, and Strategic Planning

Advance your company’s footprint

Looking to price a new drug or submit a reimbursement dossier? Enter an emerging market? Understand the HTA landscape? Develop a launch sequence or international reference pricing strategy?

Leveraging our unique, proprietary in-house data and modeling capabilities, we provide customized market analysis, reimbursement consulting, pricing models, and market access strategies. Our global team of experts means we have deep experience in every aspect of pricing and reimbursement in order to help future price setting, customer decision-making and innovative strategies to optimize market access. We are here to help you:

  • Size and seize market opportunities through market landscaping and go-to-market strategy
  • Communicate value, positioning strategy and value story development
  • Optimize reimbursement, contracting and tender management strategy
  • Evaluate the economic impact of business or policy decisions
  • Managed entry agreements, international reference pricing, pricing excellence and HTA strategy

Advisory Services

Market Research
Demonstrate the potential of pharmaceuticals, biotechnology products, medical devices and care delivery patterns on patient health outcomes, medical costs, productivity and quality of life

Reimbursement Consulting
Identify and quantify key cost drivers to develop efficient, evidence-based estimates for reimbursement and prospective payment

Healthcare Pricing Models
Develop the optimal new drug price and market entry strategy

Market Entry Analysis
Receive continuous analysis, data and online tools covering technology, reimbursement, regulations, geographic/therapeutic segment scenarios

Single-Client Reports
Partner with us for customized research on business improvement and opportunity maximization strategies

Recent Projects

Integrating HTA Requirements into Oncology R&D Process

A pharmaceutical company needed recommendations for incorporating more HTA considerations into R&D decision-making.

We researched recent HTA decisions in Australia, US, United Kingdom, France, Germany, Italy and Spain in the client’s four therapeutic areas. Our detailed case studies identified the choice of trial design, trial comparator, patient group selection, primary and secondary outcome measures, strength of correlation between surrogate and final outcomes, traits of PRO evidence and studies, and a definition of clinical relevance.

We helped the client build user-friendly HTA "checklists". The client uses these checklists to ensure its R&D personnel factor HTA considerations into future planning.


event image
IHS Markit Event 26 September 2019

Pricing & Purchasing Regional Seminar - Chicago

Follow IHS Markit Life Sciences on Twitter


Filter Sort